新入荷
再入荷
ZFN-mediated in vivo gene editing in hepatocytes leads to supraphysiologic α-Gal A activity and effective substrate reduction in Fabry mice - ScienceDirect
4.5
（2件）
タイムセール
終了まで
00
00
00
999円以上お買上げで送料無料（※）
999円以上お買上げで代引き手数料無料
999円以上お買上げで代引き手数料無料
通販と店舗では販売価格や税表示が異なる場合がございます。また店頭ではすでに品切れの場合もございます。予めご了承ください。
商品詳細情報
| 管理番号 |
新品 ：8162667663
中古 ：8162667663-1 |
メーカー | 857960aed712 | 発売日 | 2025-04-16 10:26 | 定価 | 9000円 | ||
|---|---|---|---|---|---|---|---|---|---|
| カテゴリ | |||||||||
ZFN-mediated in vivo gene editing in hepatocytes leads to supraphysiologic α-Gal A activity and effective substrate reduction in Fabry mice - ScienceDirect
ZFN-mediated in vivo gene editing in hepatocytes leads to supraphysiologic α-Gal A activity and effective substrate reduction in Fabry mice - ScienceDirect,ZFN-mediated in vivo gene editing in hepatocytes leads to supraphysiologic α-Gal A activity and effective substrate reduction in Fabry mice - ScienceDirect,Fabry Enzyme Replacement Therapy ISU303 Shows Promise: Trial | ISU Abxis Therapy Shows Efficacy, Good Safety Profile in Patients | Fabry Disease News,Critical roles of FAM134B in ER-phagy and diseases | Cell Death & Disease,Critical roles of FAM134B in ER-phagy and diseases | Cell Death & Disease,
健康・医学の作品リスト
レディースの製品
